Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-21

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the Original Application for a generic fixed-dose combination of valsartan and hydrochlorothiazide, manufactured by Mylan. The product is indicated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

ORIG AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)